-
Rajasekaran, K.; Baskaran, T.; Gnanasekaran, C., Indian Journal of Chemistry, Section A: Inorganic, Physical, Theoretical and Analytical, 1984, vol. 23, # 12, p. 1008 - 1010
作者:Rajasekaran, K.、Baskaran, T.、Gnanasekaran, C.
DOI:——
日期:——
-
Ananthakrishnanadar, P.; Varghesedharumaraj, G., Indian Journal of Chemistry, Section A: Inorganic, Physical, Theoretical and Analytical, 1983, vol. 22, # 3, p. 237 - 238
作者:Ananthakrishnanadar, P.、Varghesedharumaraj, G.
DOI:——
日期:——
-
WALKER K. A. M.; WALLACH M. B.; HIRSCHFELD D. R., J. MED. CHEM., 1981, 24, NO 1, 67-74
作者:WALKER K. A. M.、 WALLACH M. B.、 HIRSCHFELD D. R.
DOI:——
日期:——
-
1-(Naphthylalkyl)-1H-imidazole derivatives, a new class of anticonvulsant agents
作者:Keith A. M. Walker、Marshall B. Wallach、Donald R. Hirschfeld
DOI:10.1021/jm00133a015
日期:1981.1
anticonvulsant activity has been demonstrated for a large number of 1-(naphthylalkyl)-1H-imidazoles containing a variety of functional groups in the alkylene bridge. The presence of a small oxygen function in the bridge, in general, confers a high therapeutic index between anticonvulsant and depressant activity. Clinical expectations are discussed for 1-(2-naphthoylmethyl)imidazole hydrochloride (5), which is
对于在亚烷基桥中含有各种官能团的大量1-(萘基烷基)-1H-咪唑已显示出有效的抗惊厥活性。通常,桥中小的氧功能的存在在抗惊厥和抑郁活性之间赋予较高的治疗指数。讨论了1-(2-萘甲酰基甲基)咪唑盐酸盐(5)的临床期望,该盐正在开发用于人体测试。
-
Thirunarayanan; Vanangamudi; Sathiyendran, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2011, vol. 50, # 4, p. 593 - 604
作者:Thirunarayanan、Vanangamudi、Sathiyendran、Ravi
DOI:——
日期:——